STAT3 and Miyoshi myopathy: This proto-oncogene is also overexpressed when not mutated or translocated, being upregulated downstream of oncogenic pathways such as STAT3 [37] or Wnt/B-catenin [38], which are known to be activated in cancers including PEL [39] and MM [40].